<DOC>
	<DOCNO>NCT00815113</DOCNO>
	<brief_summary>Introduction : Gastric cancer world 's second large cause cancer relate death . In Western world , well Israel , malignancy le prevalent colorectal cancer , high morbidity mortality . First degree relative patient gastric cancer 1.5-fold 3-fold increase risk develop gastric cancer . In relative gastric cancer patient also carrier CagA positive strain Helicobacter pylorus , risk 8-fold . Mucosal atrophy , hypochlorhydria , high lymphoid follicle density , pan gastritis , interleukin 1 β polymorphism frequent family member gastric cancer patient associate increased risk disease . Aims : 1 . To characterize high risk individual gastric cancer development . 2 . To establish screening plan early detection prevention gastric cancer first degree relative gastric cancer patient . 3 . To validate new procedure assess risk factor development gastric cancer : gastric acid output , gastric mucin output , serum level pepsinogen I , pepsinogen II , gastrin B12 , Helicobacter pylori status [ serology , histology , urease test , 13C-urea breath test ( 13C-UBT ) ] . 4 . To assess genetic change gastric mucosa screenees comparison gastric cancer patient control . Methods : We approach 50 gastric cancer patient treat Rabin Medical Center , ask consent approach first degree relative participate study . For gastric cancer patient 4 relative ask sign informed consent undergo study procedure . For participant match control age , sex background disease , consecutive gastro esophageal reflux disease ( GERD ) patient undergo gastroscopy , ask join study . Thus , screen 50 gastric cancer patient , 200 first degree relative gastric cancer patient , 200 control .</brief_summary>
	<brief_title>Screening Gastric Cancer High-risk Population</brief_title>
	<detailed_description>High Risk Population First degree relatives patient gastric cancer 1.5-fold 3-fold increase risk develop gastric cancer ( Brenner H et al , Cancer 2000 ; 88:274-9 ) . In relative gastric cancer patient also carrier CagA positive strain H. pylorus , risk 8-fold . Mucosal atrophy , hypochlorhydria , high lymphoid follicle density , pangastritis , interleukin 1 β polymorphism frequent family member gastric cancer patient associate increased risk disease ( El-Omar EM et al , Gastroenterology 2000 ; 118:22-30 , Sepulveda A et al , Am J Gastroenterol 2002 ; 97:1365-70 ) . Helicobacter Pylori - Carcinogen Number I Helicobacter pylori main known carcinogen . The positive correlation H. pylori infection development gastric cancer well establish prove prospective , control , study , Japan ( Uemura N et al , N Engl J Med 2001 ; 345:784-9 , Fukase K et al , JAMA 2008 ; 372:392-7 ) . Genetic change Specific change ( mutation oncogens , LOH tumor suppressor gene , deletion insertion ) , different intestinal diffuse type gastric cancer , describe . Most pre-malignant change happen background long lasting chronic inflammation , follow cascade atrophy , intestinal metaplasia , dysplasia . Genetic syndrome rare family cluster gastric cancer usually attribute common H. pylorus infection . A family syndrome gastric cancer due germ-line mutation E-cadherin described , gastric cancer may part Lynch syndrome ( HNPCC ) . Mutations polymorphism IL-1b TNFa describe first degree relative gastric cancer patient , consider predictive factor cancer . Screening Gastric Cancer Screening gastric cancer gain popularity Japan , disease highly prevalent . This approach cost-effective Western word , gastric cancer incidence low , still cost-effective high-risk population : Helicobacter pylorus infect people , first degree relative gastric cancer patient , patient autoimmune atrophic gastropathy pernicious anemia , family HNPCC patient underwent partial gastrectomy . Since treatment gastric cancer effective 5-year-survival low , recommend screen population periodic gastroscopy biopsy . The finding high grade dysplasia early gastric cancer enable early intervention cure . In addition H. pylorus may diagnose gastric biopsy ( direct evaluation H &amp; E , Giemsa Genta staining , culture , PCR urease rapid test ) , mucin secretion pattern may assess immunohistochemistry PAb 's , MAb 's lectin , JCV TAg may demonstrate IMH PCR ) . Mucins Healthy Stomach Gastric Cancer Normal gastric mucus express mucin MUC1 , MUC5AC MUC6 ( Carrato C et al , Gastroenterology 1994 ; 107:160-72 ) . The development gastric carcinoma associate change mucin expression , namely decrease MUC5AC MUC6 aberrant de novo expression MUCs ( Ho SB et al , Cancer Res 1995 ; 55:2681-90 ) . Helicobacter pylori infection induces wide range change gastric mucus . There reversible alteration mucus glycosylation , affect protective function gastric mucin ( Ota H et al , Virchows Arch 1998 ; 433:419-26 ) . Screening High-Risk Phenotype In addition gastroscopy histology , gold standard screen prevention gastric cancer , several approach , non-invasive , suggest . Acid hyposecretion measure directly indirectly , mucin output measure gastric secretion collect naso-gastric tube mucin specie identify dot-blot gastric mucin ( MUC5AC , MUC6 MUC1 ) , H. pylorus status define 13C-UBT , serology stool antigen test , pepsinogen I , pepsinogen II , gastrin B12 measure serum . The combination procedure mention may contribute accurate characterization high-risk individual , suitable invasive procedure gastroscopy biopsy . Aims 1 . To characterize high risk individual gastric cancer development 2 . To establish screening plan early detection prevention gastric cancer first degree relative gastric cancer patient . 3 . To validate new procedure assess risk factor development gastric cancer : gastric acid output , gastric mucin output , serum level pepsinogen I , pepsinogen II , gastrin B12 , H. pylorus status ( serology , histology , urease test , 13C-UBT ) . 4 . To assess genetic change gastric mucosa screenees comparison gastric cancer patient control Subjects We approach 50 gastric cancer patient treat Rabin Medical Center , ask consent approach first degree relative participate study . For gastric cancer patient 4 relative ask sign informed consent undergo study procedure . For participant match control age , sex background disease , consecutive GERD patient undergo gastroscopy , ask join study . Thus , screen 200 first degree relative gastric cancer patient , 200 control . Inclusion Criteria 1 . First relative , man woman , gastric cancer patient . 2 . Signed informed consent . 3 . Age 18-60 . Exclusion Criteria 1 . Severe back ground disease . 2 . State gastric surgery . 3 . COPD , CHF , CRF disease respiratory disturbance . 4 . Deviation nasal septum , lack venous access dorsum hand technical problem prevents gastric acid collection base excess evaluation . Study design This prospective , control , 4 day study . All procedure follow accordance ethical standard committee human experimentation Rabin Medical Center , accordance Declaration Helsinki . In screen meeting participant control tell aim nature study , comprehensively informed procedure , anticipate result risk . After agree participate sign inform consent . A medical history , family history symptomatic questionnaire fill , participant schedule gastroscopy . After night fast gastroscopy perform , biopsy take needed different protocol ( see ) . Then gastric acid output , mucin output alkaline tide study perform . Blood drawn `` gastro panel '' BioHit , routine blood test , B12 , CEA , CA19-9 , CAG A serology . In another day , 13CUBT IFOBT perform .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>1 . First relative , man woman , gastric cancer patient . 2 . Signed informed consent . 3 . Age 1860 . 1 . Severe back ground disease . 2 . State gastric surgery . 3 . COPD , CHF , CRF disease respiratory disturbance . 4 . Deviation nasal septum , lack venous access dorsum hand technical problem prevents gastric acid collection base excess evaluation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Gastric cancer</keyword>
	<keyword>screen</keyword>
	<keyword>high-risk</keyword>
	<keyword>relative</keyword>
	<keyword>gastroscopy</keyword>
</DOC>